Abbott Labs CEO expects strong COVID-19 testing demand in near term
FILE PHOTO: Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermid
(Reuters) - Abbott Laboratories Chief Executive Officer Robert Ford said on Tuesday demand for COVID-19 testing has surged globally and that sales of its tests should stay strong in the near term.
"We've obviously you know, had a pretty, pretty strong last couple of months of testing and we expect that to continue here in the more immediate future," Ford said at the annual J.P. Morgan Health care conference.
He added his company has the capacity to support demand.
While testing demand will eventually dwindle, there will be a portion that is sustained, Ford said.
(Reporting by Amruta Khandekar; Editing by Aditya Soni)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott Labs (ABT) PT Raised to $135 at TD Cowen
- Jefferies: US equity ETF inflows jump to $27.8B on strong demand
- Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare
Create E-mail Alert Related Categories
General News, ReutersRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share